• 1
    Wright V. Seronegative polyarthritis: a unified concept. Arthritis Rheum 1978; 21: 61933.
  • 2
    Wright V, Moll JMH. Psoriatic arthritis. In: WrightV, MollJMH, editors. Seronegative polyarthritis. Amsterdam: North Holland Publishing; 1976. p. 169223.
  • 3
    Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 5578.
  • 4
    Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991; 30: 33945.
  • 5
    Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C, et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991; 30: 24550.
  • 6
    Scarpa R, Oriente P, Pucino A, Vignone L, Cosentini E, Minerva A, et al. The clinical spectrum of psoriatic spondylitis. Br J Rheumatol 1988; 27: 1337.
  • 7
    Veale D, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994; 33: 1338.
  • 8
    Moll JM. The place of psoriatic arthritis in the spondarthritides. Baillieres Clin Rheumatol 1994; 8: 395417.
  • 9
    McCormack GD, Barth W. Classification and diagnosis of psoriatic arthritis. In: GerberLH, EspinozaLR, editors. Psoriatic arthritis. New York: Grune and Stratton; 1985. p. 5982.
  • 10
    Barth WF. Psoriatic arthritis sine psoriasis. In: KlippelJH, DieppeP, editors. Rheumatology. London: Mosby; 1994. p. 34.13.
  • 11
    Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA)—an analysis of 220 patients. QJM 1987; 62: 12741.
  • 12
    Helliwell PS, Wright V. Psoriatic arthritis: clinical features. In: KlippelJH, DieppeP, editors. Rheumatology. London: Mosby; 1994. p. 31.18.
  • 13
    Gladmann DD. Psoriatic arthritis. In: MaddisonPJ, IsenbergDA, WooP, GlassDN, editors. Oxford textbook of rheumatology. New York: Oxford University Press; 1998. p. 107184.
  • 14
    Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986; 13: 58692.
  • 15
    Beaulieu AD, Roy R, Mathon G, Morissette J, Latulippe L, Lang JY, et al. Psoriatic arthritis: risk factors for patients with psoriasis—a study based on histocompatibility antigen frequencies. J Rheumatol 1983; 10: 6336.
  • 16
    Murray C, Mann DL, Gerber LN, Barth W, Perlmann S, Decker JL, et al. Histocompatibility alloantigens in psoriasis and psoriatic arthritis: evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest 1980; 66: 6705.
  • 17
    Armstrong RD, Panayi GS, Welsh KI. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann Rheum Dis 1983; 42: 1426.
  • 18
    Sakkas LI, Loqueman N, Bird H, Vaughan RW, Welsh KI, Panayi GS. HLA class II and T cell receptor gene polymorphisms in psoriatic arthritis and psoriasis. J Rheumatol 1990; 17: 148790.
  • 19
    Resnick D, Niwayama G. Psoriatic arthritis. In: ResnickD, editor. Diagnosis of bone and joint disorders. Philadelphia: Saunders; 1995. p. 1075102.
  • 20
    Watt I. Basic differential diagnosis of arthritis. Eur Radiol 1997; 7: 34451.
  • 21
    Fournie B, Granel J, Bonnet M, Dromer C, Pages M, Billey T, et al. Incidence of signs indicating psoriatic rheumatism in radiological involvement of fingers and toes. Rev Rhum 1992; 59: 17780.
  • 22
    Namey TC, Rosenthall L. Periarticular uptake of 99mtechnetium diphosphonate in psoriatics: correlation with cutaneous activity. Arthritis Rheum 1976; 19: 60712.
  • 23
    Hahn K, Thiers G, Eibner D. Bone scintigraphy in psoriasis. Nuklearmedizin 1980; 19: 17886.
  • 24
    Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skel Radiol 1995; 24: 3515.
  • 25
    Jevtic V, Rozman B, Kos-Golja M, Watt I. MR imaging in seronegative spondyloarthritis. Radiologe 1986; 36: 62431.
  • 26
    McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P. Characteristic magnetic resonance imaging entheseal changes in knee synovitis in spondylarthropathy. Arthritis Rheum 1998; 41: 694700.
  • 27
    McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Ridgway J, et al. An anatomical explanation for good prognosis rheumatoid arthritis. Lancet 1999; 353: 1234.
  • 28
    Wong WM, Howell WM, Coy SD, Cawley MI, Smith JL. Interleukin-2 is found in the synovium of psoriatic arthritis and spondyloarthritis, not in rheumatoid arthritis. Scand J Rheumatol 1996; 25: 23945.
  • 29
    Pitzalis C, Cauli A, Pipitone N, Smith C, Barker J, Marchesoni A, et al. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum 1996; 39: 13745.
  • 30
    Lehtinen A, Taavitsainen M, Leirisalo-Repo M. Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy. Clin Exp Rheumatol 1994; 2: 1438.
  • 31
    Hanly JG, Russell ML, Gladman DD. Psoriatic spondyloarthropathy: a long term prospective study. Ann Rheum Dis 1988; 47: 38693.
  • 32
    Lambert JR, Wright V. Psoriatic spondylitis: a clinical and radiological description of the spine in psoriatic arthritis. QJM 1977; 46: 41125.
  • 33
    Salvarani C, Cantini F, Olivieri I, Macchioni P, Niccoli L, Padula A, et al. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J Rheumatol 1997; 24: 110610.
  • 34
    Olivieri I, Barozzi L, Favaro L, Pierro A, de Matteis M, Borghi C, et al. Dactylitis in patients with seronegative spondylarthropathy: assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum 1996; 39: 15248.
  • 35
    Kahn MF. Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. Curr Opin Rheumatol 1993; 5: 42835.
  • 36
    Maugars Y, Berthelot JM, Ducloux JM, Prost A. SAPHO syndrome: a followup study of 19 cases with special emphasis on enthesis involvement. J Rheumatol 1995; 22: 213541.
  • 37
    Sonozaki H, Kawashima M, Hongo O, Yaoita H, Ikeno M, Matsuura M, et al. Incidence of arthro-osteitis in patients with pustulosis palmaris et plantaris. Ann Rheum Dis 1981; 40: 5547.
  • 38
    Sonozaki H, Mitsui H, Miyanaga Y, Okitsu K, Igarashi M, Hayashi Y, et al. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis 1981; 40: 54753.
  • 39
    Toussirot E, Dupond JL, Wendling D. Spondylodiscitis in SAPHO syndrome: a series of eight cases. Ann Rheum Dis 1997; 56: 528.
  • 40
    Schroder K, Goerdt S, Sieper J, Krasagakis K, Almond-Roesler B, Orfanos CE. Psoriatic onycho-pachydermo-periostitis (POPP). Hautarzt 1997; 48: 5003.
  • 41
    Goupille P, Vedere V, Roulot B, Brunais J, Valat JP. Incidence of osteoperiostitis of the great toe in psoriatic arthritis. J Rheumatol 1996; 23: 15536.
  • 42
    Boisseau-Garsaud AM, Beylot-Barry M, Doutre MS, Beylot C, Baran R. Psoriatic onycho-pachydermo-periostitis: a variant of psoriatic distal interphalangeal arthritis? Arch Dermatol 1996; 132: 17680.
  • 43
    Carr AJ, Cole WG, Roberton DM, Chow CW. Chronic multifocal osteomyelitis. J Bone Joint Surg Br 1993; 75: 58291.
  • 44
    Zanolli MD, Wikle JS. Joint complaints in psoriasis patients. Int J Dermatol 1992; 31: 48891.
  • 45
    Stern RS. The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 1985; 12: 31520.
  • 46
    McGonagle D, Gibbon W, Emery P. Classification of arthritis based on enthesitis. Lancet 1998; 352: 113740.
  • 47
    Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10: 402531.
  • 48
    Gladman DD. Psoriatic arthritis. In: KhanMA, editor. Spine: state of the art reviews. Ankylosing spondylitis and related spondyloarthropathies. Philadelphia: Hanley and Belfus; 1990. p. 63756.
  • 49
    Märker-Hermann E, Fassbender H-G, Kessler S, Thomssen H, Meyer zum B üschenfelde K-H, Blessing M. Transgenic mice with an epidermal overexpression of bone morphogenic protein-6 (BMP-6) present with psoriatic skin lesions and osteoarthropathy [abstract]. Arthritis Rheum 1997; 40 Suppl 9: S261.
  • 50
    Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe HA. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992; 19: 11159.
  • 51
    Espinoza LR, Vasey FB, Espinoza CG, Bocanegra TS, Germain BF. Vascular changes in psoriatic synovium: a light and electron microscopic study. Arthritis Rheum 1982; 25: 67784.
  • 52
    Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, FitzGerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993; 36: 893900.
  • 53
    Jones SM, Dixey J, Hall ND, McHugh NJ. Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of patients with psoriatic arthritis. Br J Rheumatol 1997; 36: 74857.
  • 54
    Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099112.
  • 55
    Blessing M, Schirmacher P, Kaiser S. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 1996; 135: 22739.
  • 56
    Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 33: 8349.
  • 57
    Lee RT, Briggs WH, Cheng GC, Rossiter HB, Libby P, Kupper T. Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. J Immunol 1997; 159: 50848.
  • 58
    Carroll JM, Romero MR, Watt FM. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995; 83: 95768.
  • 59
    Schon MP, Detmar M, Parker CM. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med 1997; 3: 1838.
  • 60
    Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995; 1: 4427.
  • 61
    Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98: 187887.
  • 62
    Goodfield M. Skin lesions in psoriasis. Baillieres Clin Rheumatol 1994; 8: 295316.